ACT-709478

  • CAT Number: I019341
  • CAS Number: 1838651-58-3
  • Molecular Formula: C₂₂H₁₈F₃N₅O
  • Molecular Weight: 425.41
  • Purity: ≥95%
Inquiry Now

ACT-709478 (Cat No.:I019341) is a chemical compound with potential pharmacological properties. However, limited information is available regarding its specific characteristics and applications. Further research is needed to fully understand the compound’s mode of action and potential therapeutic uses. As a newer compound, ACT-709478 may be undergoing investigation in areas such as drug discovery, medicinal chemistry, or preclinical studies.

Catalog Number I019341
CAS Number 1838651-58-3
Molecular Formula

C₂₂H₁₈F₃N₅O

Purity 95%
Storage Store at -20°C
IUPAC Name N-[1-[(5-cyanopyridin-2-yl)methyl]pyrazol-3-yl]-2-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]acetamide
InChI InChI=1S/C22H18F3N5O/c23-22(24,25)21(8-9-21)17-4-1-15(2-5-17)11-20(31)28-19-7-10-30(29-19)14-18-6-3-16(12-26)13-27-18/h1-7,10,13H,8-9,11,14H2,(H,28,29,31)
InChIKey LSYANGLAZUZYFX-UHFFFAOYSA-N
SMILES C1CC1(C2=CC=C(C=C2)CC(=O)NC3=NN(C=C3)CC4=NC=C(C=C4)C#N)C(F)(F)F
Reference

[1]. Bezençon O, et al. Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies. J Med Chem. 2017 Dec 14;60(23):9769-9789.

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!